- Report
- February 2024
- 83 Pages
Global
From €3500EUR$3,980USD£3,098GBP
- Report
- October 2024
- 270 Pages
China
From €3768EUR$4,000USD£3,222GBP
- Report
- October 2024
- 135 Pages
China
From €1696EUR$1,800USD£1,450GBP
Ceftezole is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat a wide range of bacterial infections. Ceftezole is effective against a variety of Gram-positive and Gram-negative bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, and Escherichia coli. It is also used to treat urinary tract infections, skin infections, and respiratory tract infections. Ceftezole is available in both oral and intravenous formulations.
The ceftezole market is highly competitive, with a number of companies offering various formulations of the drug. Companies such as Pfizer, Merck, and GlaxoSmithKline are some of the major players in the market. Other companies include AstraZeneca, Sanofi, and Novartis. These companies are engaged in the development, manufacturing, and marketing of ceftezole and other antibiotics. Show Less Read more